| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | Sep 30, 2024 | Inmune Bio, Inc. | CFO | Buy | 72.5 | +10,000 | 0.78% | ✗ | $52.9K |
| Sep 12, 2024 | Sep 16, 2024 | Inmune Bio, Inc. | CFO | Buy | 68.8 | +7,690 | 0.61% | ✗ | $49K |
| Apr 19, 2024 | Apr 24, 2024 | Inmune Bio, Inc. | CFO | Buy | 82.5 | +18,028 | 1.44% | ✗ | $150K |
| Mar 17, 2023 | Mar 20, 2023 | Inmune Bio, Inc. | CFO | Buy | 61.3 | +2,500 | 0.20% | ✗ | $16.1K |
| May 26, 2022 | May 31, 2022 | Inmune Bio, Inc. | CFO | Buy | 72.5 | +10,700 | 0.87% | ✗ | $68.6K |
| Nov 3, 2021 | Nov 4, 2021 | Inmune Bio, Inc. | CFO | Sell | 55.0 | -1,025 | -0.08% | ✓ | $20.5K |
| Oct 27, 2021 | Oct 29, 2021 | Inmune Bio, Inc. | CFO | Sell | 53.8 | -2,079 | -0.17% | ✓ | $41.6K |
| Oct 22, 2021 | Oct 26, 2021 | Inmune Bio, Inc. | CFO | Sell | 55.0 | -1,155 | -0.09% | ✓ | $23.1K |
| Jul 7, 2021 | Jul 9, 2021 | Inmune Bio, Inc. | CFO | Sell | 38.8 | -25,000 | -2.04% | ✓ | $501.5K |
| Aug 20, 2019 | Aug 21, 2019 | Inmune Bio, Inc. | CFO | Buy | 61.3 | +3,000 | 0.25% | ✗ | $17K |
| Jun 3, 2019 | Jun 4, 2019 | Inmune Bio, Inc. | CFO | Buy | 72.5 | +10,000 | 0.83% | ✗ | $60K |
| May 6, 2019 | May 20, 2019 | Inmune Bio, Inc. | CFO | Buy | 65.0 | +5,000 | 0.41% | ✗ | $53.6K |
| May 6, 2019 | May 7, 2019 | Inmune Bio, Inc. | CFO | Buy | 61.3 | +5,000 | 0.41% | ✗ | $45K |